Clinical trials
Phase 2 Demyelinating Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2009 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 3 |
| Recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | 4 |
| Novartis Pharmaceuticals | 2 |
| Boston Scientific Corporation | 1 |
| Clene Nanomedicine | 1 |
| Queen Mary University of London | 1 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 1 |
| Sundance Biosciences, Inc. | 1 |
| University of Calgary | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Demyelinating Diseases | 12 |
| Multiple Sclerosis | 7 |
| Multiple Sclerosis, Relapsing-Remitting | 6 |
| Autoimmune Diseases | 3 |
| Immune System Diseases | 2 |
| Atrophy | 1 |
| Autoimmune Diseases of the Nervous System | 1 |
| Camurati-Engelmann Syndrome | 1 |
| Diffuse Cerebral Sclerosis of Schilder | 1 |
| Inflammation | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.